Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES D. CARNEGIE & CO IN CONNECTION WITH ITS LISTING ON NASDAQ STOCKHOLM’S MAIN MARKET
Mandate

VINGE ADVISES D. CARNEGIE & CO IN CONNECTION WITH ITS LISTING ON NASDAQ STOCKHOLM’S MAIN MARKET

May 08, 2015

D. Carnegie & Co (publ) has been approved for listing on Nasdaq Stockholm’s main market with the first day of trading on 12 May 2015.

D. Carnegie & Co is a property company focusing on residential properties in the Greater Stockholm region and other growth areas. The company’s business concept is to own property portfolios slated for a gradual renovation of apartments in conjunction with the natural turnover of tenants.

Vinge’s team primarily consisted of Jesper Schönbeck, Rikard Lindahl, Adam Sandberg and Nils‑Fredrik Dehlin.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025